Gilead to acquire Myogen for $2.5 billion
113587
Gilead Sciences Inc.  said on  Monday it will acquire Myogen Inc.  for $2.5 billion,  gaining control of Myogen's experimental heart medicines.
226932
Billionaire financier Carl Icahn offered to buy Mylan Laboratories Inc., the largest US maker of generic medicines, for about $5.38 billion to block Mylan&#39;s proposed purchase of King Pharmaceuticals Inc.
665690
The developing biopharmaceutical company announces a share offering.
348292
Masonite International Corp., a maker of doors and other construction products, said Wednesday that it agreed to be bought out by a private equity group for about $2.5 billion.
287707
Serono SA , one of the world's largest biotechnology companies, was bought yesterday by German chemical giant Merck KGaA in a deal worth more than $13 billion.
341555
The Riverdeep Group was close to a deal to acquire the textbook publisher Houghton Mifflin for about $3.5 billion, including debt.
639985
As part of its push to become a bigger player in cancer drugs, Genzyme Corp. of Cambridge said yesterday it will buy out business partner Bioenvision Inc. of New York for $345 million , consolidating its ownership of a cancer treatment to which the two companies had been sharing rights.
112646
Nestle SA completed its $2.5 billion takeover of Novartis Medical Nutrition, the food and drinks giant said Monday.
695477
Generic drug maker Mylan Laboratories Inc.  said on Friday it expects to raise $993.6 million after pricing a public offering of notes and common shares, with proceeds intended for global operations and potential acquisitions.
163335
The deal, for $350 million in cash and stock, is the second sizable acquisition Yahoo has announced this month.
337666
SAN FRANCISCO -- Billionaire investor Carl C. Icahn was given clearance by US antitrust regulators to purchase shares in Biogen Idec Inc., the world's biggest maker of drugs for multiple sclerosis.
599973
Investor Carl Icahn issued a $20-per-share bid to acquire Mylan Laboratories Inc. on Friday and said &quot;at least&quot; three other potential buyers in the generic drug industry could offer more.
291560
Gilead Sciences, which makes drugs to treat H.I.V., announced plans to buy a rival, Myogen, for about $2.5 billion in cash.
537376
Philips will buy U.S. medical products company Respironics $5.2 billion, its biggest ever acquisition, as it expands in the fast-growing healthcare sector.
34170
LOS ANGELES (CBS.MW) -- Shares of Gilead Sciences climbed Thursday, touching a 52-week high at one point, after the biotechnology firm reported positive results from its recently approved HIV drug Truvada.
618409
In a surprise attempt by a Cambridge biotechnology company to trump a takeover bid by one of its neighbors, Millennium Pharmaceuticals Inc. yesterday said it had reached a $515 million deal to buy a small Canadian drug firm that Genzyme Corp. has been trying to buy since late last month.
624242
Smiths Group announced the acquisition of Medex, a privately held maker of medical devices. The cost of the deal was reported to be $925 million.